Peptide Side Effects: Complete Guide to Every Known Risk by Type

These are the best-documented peptides because they're approved medications with extensive clinical trial data.

Very Common (>10% of users): - Nausea (20-44% — worst during dose titration, usually improves) - Diarrhoea (15-30%) - Constipation (10-24%) - Vomiting (5-18%) - Abdominal pain (5-15%) - Headache (10-14%)

Common (1-10%): - Sulfur burps (particularly tirzepatide) - Injection site reactions (redness, swelling) - Fatigue - Dizziness - Gastroesophageal reflux (GORD) - Flatulence

Serious (Rare but Important): - Pancreatitis (0.1-0.3%) — seek immediate medical attention for severe abdominal pain - Gallbladder disease (cholelithiasis) — rapid weight loss increases gallstone risk - Thyroid C-cell tumours — precautionary warning based on rodent studies (not observed in humans) - Acute kidney injury — usually secondary to dehydration from vomiting - Muscle loss — GLP-1 medications cause 25-40% lean mass loss alongside fat loss. Resistance training and high protein intake (1.6-2g/kg) are essential - Hypoglycaemia — mainly when combined with insulin or sulfonylureas - 'Ozempic face' — facial volume loss from rapid weight loss

Long-term Unknowns: - Effects of 5+ years of continuous use - Weight regain trajectory after stopping (current data: 2/3 of weight regained within 1 year) - Fertility effects (GLP-1 medications must be stopped 2 months before conception)

Less documented than GLP-1s because most lack formal clinical trials. Side effects from clinical research and community reports:

Common: - Water retention and bloating (very common, dose-dependent) - Increased appetite (especially GHRP-6 and MK-677) - Tingling/numbness in hands (carpal tunnel-like, from GH elevation) - Fatigue/lethargy initially - Flushing after injection - Vivid dreams

Moderate Concerns: - Elevated fasting blood glucose — GH is counter-regulatory to insulin. Monitor HbA1c - Insulin resistance with prolonged use — particularly MK-677 - Cortisol elevation (GHRP-2, GHRP-6, Hexarelin — not Ipamorelin) - Prolactin elevation (GHRP-2, Hexarelin) - Joint pain from excessive GH elevation

Serious Risks: - Potential acceleration of existing tumour growth (GH/IGF-1 are growth factors) — anyone with cancer history should avoid - Pituitary desensitisation with continuous use (tolerance) - MK-677 specific: can worsen sleep apnoea, may affect heart failure outcomes

By Compound (Cleanest to Most Side Effects): 1. Ipamorelin — minimal cortisol/prolactin elevation (cleanest) 2. CJC-1295 — may cause facial flushing, moderate water retention 3. Sermorelin — similar to CJC-1295, shorter-acting 4. GHRP-2 — mild cortisol and prolactin increase, moderate appetite boost 5. MK-677 — strong appetite increase, insulin resistance risk, longest-acting 6. GHRP-6 — strongest appetite increase, cortisol/prolactin elevation 7. Hexarelin — highest tolerance development, cortisol/prolactin elevation

BPC-157: Formal side effect data is limited because there are no large human trials. Based on preclinical studies and community reports:

Commonly Reported: - Injection site redness (mild, temporary — 5-15 minutes) - Occasional mild headache in first few days - Slight nausea (rare, usually dose-related) - Mild dizziness (very rare)

Not Commonly Reported: - No significant hormonal effects documented - No cardiovascular effects documented at research doses - No liver or kidney toxicity in preclinical studies - No tolerance development reported

Theoretical Concerns (Unproven): - Angiogenesis promotion could theoretically feed tumour blood supply — anyone with active cancer should avoid - Long-term effects of exogenous BPC-157 on gastric acid regulation are unknown

TB-500:

Commonly Reported: - Injection site reactions (redness, swelling — more common than BPC-157) - Temporary head rush/lightheadedness after injection - Mild flu-like symptoms in first few days (immune modulation effect) - Fatigue for 24-48 hours after initial doses

Less Common: - Mild nausea - Temporary low blood pressure

Theoretical Concerns: - As an immune modulator, TB-500 could theoretically interact with autoimmune conditions - Angiogenesis promotion — same cancer concern as BPC-157

Overall: Both BPC-157 and TB-500 are reported as very well-tolerated by most community users. The side effect profiles appear favourable compared to NSAIDs or corticosteroid injections, but this comparison is inherently flawed because the peptides lack the rigorous safety data that prescription medications have.

Regardless of which peptide you're using, seek immediate medical attention if you experience:

Emergency (999/A&E): - Severe abdominal pain (potential pancreatitis or gallbladder emergency) - Difficulty breathing or swelling of face/throat (anaphylaxis) - Signs of severe dehydration: confusion, rapid heartbeat, dark urine, dizziness - Chest pain or irregular heartbeat - Loss of consciousness

Urgent (GP Same Day/111): - Persistent vomiting (>24 hours) — risk of dehydration and electrolyte imbalance - Signs of injection site infection: increasing redness, warmth, swelling, pus, red streaking - Yellowing of skin or eyes (liver concern) - Unexplained severe headache - Significant mood changes or suicidal thoughts - Blood in stool or urine

Non-Urgent (GP Appointment): - Persistent mild nausea affecting eating - New or worsening joint pain - Significant hair changes (thinning or unusual growth) - Changes to existing moles (if using melanocortin peptides) - Menstrual cycle changes - Persistent fatigue or sleep disturbance

General Rule: If something doesn't feel right, stop the peptide and consult a healthcare professional. The cost of a GP visit is nothing compared to the risk of ignoring a serious side effect.

*This guide is for educational purposes only. It is not a substitute for professional medical advice. Always consult your GP or call 111 for medical concerns.*